The complex P2X7 receptor/inflammasome in perivascular fat tissue of heavy smokers

European Journal of Clinical Investigation

Volumn 44, Issue 3, 2014, Pages 295-302

  Rossi, Chiara ^a   Santini, Eleonora ^a   Chiarugi, Massimo ^a   Salvati, Antonio ^a   Comassi, Mario ^a   Vitolo, Edoardo ^a   Madec, Stephanie ^b   Solini, Anna ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITÉ DE BREST   (France)

Author keywords

Inflammasome; P2X7 receptor; Perivascular adipose tissue; Smoking

Indexed keywords

CARRIER PROTEIN; CCL2 PROTEIN, HUMAN; CYTOSKELETON PROTEIN; IL1B PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; INFLAMMASOME; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; NLRP3 PROTEIN, HUMAN; PLASMA RETINOL BINDING PROTEIN; PURINERGIC P2X7 RECEPTOR; PYCARD PROTEIN, HUMAN; RBP4 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ADULT; ARTICLE; CASE CONTROL STUDY; CYTOLOGY; FEMALE; GENE EXPRESSION PROFILING; GENETICS; HUMAN; IMMUNOLOGY; INFLAMMATION; INTRAABDOMINAL FAT; MALE; MESENTERIC ARTERY; METABOLISM; MIDDLE AGED; PERIVASCULAR ADIPOSE TISSUE; SEVERITY OF ILLNESS INDEX; SMOKING;

INFLAMMASOME; P2X7 RECEPTOR; PERIVASCULAR ADIPOSE TISSUE; SMOKING;

ADIPOCYTES; ADULT; CARRIER PROTEINS; CASE-CONTROL STUDIES; CASPASE 1; CHEMOKINE CCL2; CYTOSKELETAL PROTEINS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; INFLAMMASOMES; INFLAMMATION; INTERLEUKIN-18; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTRA-ABDOMINAL FAT; MALE; MESENTERIC ARTERIES; MIDDLE AGED; RECEPTORS, PURINERGIC P2X7; RETINOL-BINDING PROTEINS, PLASMA; SEVERITY OF ILLNESS INDEX; SMOKING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84893728613     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12232     Document Type: Article

References (38)

1. Erhardt L. Cigarette smoking: an undertreated risk factor for cardiovascular disease. Atherosclerosis 2009;205:23-32.
2. Shah AM, Pfeffer MA, Hartley LH, Moyé LA, Gersh BJ, Rutherford JD et al. Risk of all-cause mortality, recurrent myocardial infarction, and heart failure hospitalization associated with smoking status following myocardial infarction with left ventricular dysfunction. Am J Cardiol 2010;106:911-6.
3. Liu J, Liang Q, Frost-Pineda K, Muhammad-Kah R, Rimmer L, Roethig H et al. Relationship between biomarkers of cigarette smoke exposure and biomarkers of inflammation, oxidative stress, and platelet activation in adult cigarette smokers. Cancer Epidemiol Biomarkers Prev 2011;20:1760-9.
4. Brunner H, Cockcroft JR, Deanfield J, Donald A, Ferrannini E, Halcox J et al. Endothelial function and dysfunction. Part II: association with cardiovascular risk factors and diseases. A statement by the Working Group on endothelins and endothelial factors of the European society of hypertension. J Hypertens 2005;23:233-46.
5. Linna MS, Ahotupa M, Irjala MK, Pöllänen P, Huhtaniemi I, Mäkinen J et al. Smoking and low serum testosterone associates with high concentration of oxidized LDL. Ann Med 2008;40:634-40.
6. Eberly LE, Prineas R, Cohen JD, Vazquez G, Zhi X, Neaton JD et al. Metabolic syndrome: risk factor distribution and 18-year mortality in the multiple risk factor intervention trial. Diabetes Care 2006;29:123-30.
7. Cai H, Huang J, Xu G, Yang Z, Liu M, Mi Y et al. Prevalence and determinants of metabolic syndrome among women in Chinese rural areas. PLoS One 2012;7:e36936.
8. Tentolouris C, Tousoulis D, Davies G, Tsioufis C, Kallikazaros I, Michailidis A et al. Effects of smoking on nitric oxide synthesis in epicardial normal and atheromatous coronary arteries. Int J Cardiol 2004;95:69-73.
9. Ashikaga T, Nishizaki M, Fujii H, Niki S, Maeda S, Yamawake N et al. Examination of the microcirculation damage in smokers versus nonsmokers with vasospastic angina pectoris. Am J Cardiol 2007;100:962-4.
10. Li ZY, Wang P, Miao CY. Adipokines in inflammation, insulin resistance and cardiovascular disease. Clin Exp Pharmacol Physiol 2011;38:888-96.
11. Matsuzawa Y, Funahashi T, Nakamura T. The concept of metabolic syndrome: contribution of visceral fat accumulation and its molecular mechanism. J Atheroscler Thromb 2011;18:629-39.
12. Britton KA, Fox CS. Ectopic fat depots and cardiovascular disease. Circulation 2011;124:e837-41.
13. Owen MK, Witzmann FA, McKenney ML, Lai X, Berwick ZC, Moberly SP et al. Perivascular adipose tissue potentiates contraction of coronary vascular smooth muscle: influence of obesity. Circulation 2013;128:9-18.
14. Verlohren S, Dubrovska G, Tsang SY, Essin K, Luft FC, Huang Y et al. Visceral periadventitial adipose tissue regulates arterial tone of mesenteric arteries. Hypertension 2004;44:271-6.
15. Rathinam VA, Vanaja SK, Fitzgerald KA. Regulation of inflammasome signaling. Nat Immunol 2012;13:333-42.
16. Deplano S, Cook HT, Russell R, Franchi L, Schneiter S, Bhangal G et al. P2X7 receptor-mediated Nlrp3-inflammasome activation is a genetic determinant of macrophage-dependent crescentic glomerulonephritis. J Leukoc Biol 2013;93:127-34.
17. Piccini A, Carta S, Tassi S, Lasiglié D, Fossati G, Rubartelli A. ATP is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1beta and IL-18 secretion in an autocrine way. Proc Natl Acad Sci U S A 2008;105:8067-72.
18. Stienstra R, van Diepen JA, Tack CJ, Zaki MH, van de Veerdonk FL, Perera D et al. Inflammasome is a central player in the induction of obesity and insulin resistance. Proc Natl Acad Sci U S A 2011;108:15324-9.
19. Madec S, Rossi C, Chiarugi M, Santini E, Salvati A, Ferrannini E et al. Adipocyte P2X7 receptors expression: a role in modulating inflammatory response in subjects with metabolic syndrome? Atherosclerosis 2011;219:552-8.
20. Mortaz E, Henricks PA, Kraneveld AD, Givi ME, Garssen J, Folkerts G. Cigarette smoke induces the release of CXCL-8 from human bronchial epithelial cells via TLRs and induction of the inflammasome. Biochim Biophys Acta 2011;1812:1104-10.
21. Gidlöf O, Smith JG, Melander O, Lövkvist H, Hedblad B, Engström G et al. A common missense variant in the ATP receptor P2X7 is associated with reduced risk of cardiovascular events. PLoS One 2012;7:e37491.
22. Eltom S, Stevenson CS, Rastrick J, Dale N, Raemdonck K, Wong S et al. P2X7 receptor and caspase 1 activation are central to airway inflammation observed after exposure to tobacco smoke. PLoS One 2011;6:e24097.
23. Lucattelli M, Cicko S, Müller T, Lommatzsch M, de Cunto G, Cardini S et al. P2X7 receptor signalling in the pathogenesis of smoke-induced lung inflammation and emphysema. Am J Respir Cell Mol Biol 2011;44:423-9.
24. Schweitzer KS, Johnstone BH, Garrison J, Rush NI, Cooper S, Traktuev DO et al. Adipose stem cell treatment in mice attenuates lung and systemic injury induced by cigarette smoking. Am J Respir Crit Care Med 2011;183:215-25.
25. Di Virgilio F. Liaisons dangereuses: P2X(7) and the inflammasome. Trends Pharmacol Sci 2007;28:465-72.
26. Lalu MM, Cena J, Chowdhury R, Lam A, Schulz R. Matrix metalloproteinases contribute to endotoxin and interleukin-1beta- induced vascular dysfunction. Br J Pharmacol 2006;149:31-42.
27. White LR, Juul R, Skaanes KO, Aasly J. Cytokine enhancement of endothelin ET(B) receptor-mediated contraction in human temporal artery. Eur J Pharmacol 2000;406:117-22.
28. Ji X, Naito Y, Weng H, Endo K, Ma X, Iwai N. P2X7 deficiency attenuates hypertension and renal injury in deoxycorticosterone acetate-salt hypertension. Am J Physiol Renal Physiol 2012;303:F1207-15.
29. Ji X, Naito Y, Hirokawa G, Weng H, Hiura Y, Takahashi R et al. P2X(7) receptor antagonism attenuates the hypertension and renal injury in Dahl salt-sensitive rats. Hypertens Res 2012;35:173-9.
30. Trøseid M, Seljeflot I, Hjerkinn EM, Arnesen H. Interleukin-18 is a strong predictor of cardiovascular events in elderly men with the metabolic syndrome: synergistic effect of inflammation and hyperglycemia. Diabetes Care 2009;32:486-92.
31. Nakamura A, Shikata K, Hiramatsu M, Kakatou T, Kitamura T, Wada J et al. Serum interleukin-18 levels are associated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetes. Diabetes Care 2005;28:2890-5.
32. Bauer CM, Zavitz CC, Botelho FM, Lambert KN, Brown EG, Mossman KL et al. Treating viral exacerbations of chronic obstructive pulmonary disease: insights from a mouse model of cigarette smoke and H1N1 influenza infection. PLoS One 2010;5:e13251.
33. Piemonti L, Calori G, Lattuada G, Mercalli A, Ragogna F, Garancini MP et al. Association between plasma monocyte chemoattractant protein-1 concentration and cardiovascular disease mortality in middle-aged diabetic and nondiabetic individuals. Diabetes Care 2009;32:2105-10.
34. Barbieri SS, Zacchi E, Amadio P, Gianellini S, Mussoni L, Weksler BB et al. Cytokines present in smokers' serum interact with smoke components to enhance endothelial dysfunction. Cardiovasc Res 2011;90:475-83.
35. Welsh P, Woodward M, Rumley A, Lowe G. Associations of plasma pro-inflammatory cytokines, fibrinogen, viscosity and C-reactive protein with cardiovascular risk factors and social deprivation: the fourth Glasgow MONICA study. Br J Haematol 2008;141:852-61.
36. Wu H, Wei L, Bao Y, Lu J, Huang P, Liu Y et al. Fenofibrate reduces serum retinol-binding protein-4 by suppressing its expression in adipose tissue. Am J Physiol Endocrinol Metab 2009;296:E628-34.
37. Pauwels NS, Bracke KR, Maes T, Pilette C, Joos GF, Brusselle GG. The role of interleukin-6 in pulmonary and systemic manifestations in a murine model of chronic obstructive pulmonary disease. Exp Lung Res 2010;36:469-83.
38. Helmersson J, Larsson A, Vessby B, Basu S. Active smoking and a history of smoking are associated with enhanced prostaglandin F(2alpha), interleukin-6 and F2-isoprostane formation in elderly men. Atherosclerosis 2005;181:201-7.